[FUNDRAISING] Established in Bari in 2014, Beforpharma provides radiopharmaceutical services to public and private nuclear medicine companies and healthcare institutions in Italy and globally. The company specializes in radiopharmaceutical research and production, having successfully executed projects in 10 different countries. The range of services has varied, encompassing GMP and quality control consulting, regulatory affairs, training, as well as project management for radiopharmaceutical facilities construction overseas. In February 2023, Beforpharma secured a patent for the radiolabeling process of 68Ga-PSMA radiopharmaceutical. Currently, Beforpharma is involved in small-scale preparation of radiopharmaceuticals (in particular, 68Ga-PSMA and 68Ga-DOTATOC) at the hospital radiopharmacy.
| Website | http://www.beforpharma.com |
| Employees | 12 (8 on RocketReach) |
| Founded | 2014 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Nuclear Medicine, Healthcare, Pharmaceutical Research, Nuclear Medicine Technology, Pharmaceutical, Healthcare Services, Drug Development, Medical Isotopes, Medical Imaging, Diagnostic Imaging, Radiotherapy, Biotechnology, Drug Discovery, Diagnostic, Oncology, Precision Medicine, Clinical Trials |
| Competitors | Sorrento Therapeutics, Inc., Moderna Therapeutics, Amgen, Gilead Sciences, Pfizer, Novartis, Johnson & Johnson, Merck & Co., Inc., Regeneron, Roche +37 more (view full list) |
Looking for a particular BeForPharma employee's phone or email?
BeForPharma Questions
Roberto la Forgia is the CEO of BeForPharma.
8 people are employed at BeForPharma.
Top BeForPharma Employees
Related Companies
